Graphite Bio, Inc.

Graphite Bio, Inc.verified

GRPH

Price:

$3.18

Market Cap:

$185.19M

Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression; GPH201 for the treatment of X-linked severe combined immunodeficiency syndrome; and GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 20...[Read more]

Industry

Biotechnology

IPO Date

2021-06-25

Stock Exchange

NASDAQ

Ticker

GRPH

The Enterprise Value as of September 2024 (TTM) for Graphite Bio, Inc. (GRPH) is -15007658.00

According to Graphite Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -15007658.00. This represents a change of 36.40% compared to the average of -11002379.68 of the last 4 quarters.

Graphite Bio, Inc. (GRPH) Historical Enterprise Value (quarterly & annually)

How has GRPH Enterprise Value performed in the past?

The mean historical Enterprise Value of Graphite Bio, Inc. over the last ten years is 196.68M. The current -15007658.00 Enterprise Value has changed -863.07% with respect to the historical average. Over the past ten years (40 quarters), GRPH's Enterprise Value was at its highest in in the March 2021 quarter at 830.85M. The Enterprise Value was at its lowest in in the March 2024 quarter at -95186934.62.

Quarterly (TTM)
Annual

Average

196.68M

Median

140.24M

Minimum

-36119432.80

Maximum

612.67M

Graphite Bio, Inc. (GRPH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Graphite Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 124.58%

Maximum Annual Enterprise Value = 612.67M

Minimum Annual Increase = -2349.66%

Minimum Annual Enterprise Value = -36119432.80

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023-36119432.80-125.75%
2022140.24M-2349.66%
2021-6234019.82-101.02%
2020612.67M124.58%

Graphite Bio, Inc. (GRPH) Average Enterprise Value

How has GRPH Enterprise Value performed in the past?

The current Enterprise Value of Graphite Bio, Inc. (GRPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

32.63M

5-year avg

196.68M

10-year avg

196.68M

Graphite Bio, Inc. (GRPH) Enterprise Value vs. Peers

How is GRPH’s Enterprise Value compared to its peers?

Graphite Bio, Inc.’s Enterprise Value is less than Assembly Biosciences, Inc. (95.68M), less than Instil Bio, Inc. (502.30M), less than Nuvation Bio Inc. (1.01B), greater than Achilles Therapeutics plc (-61656377.00), less than NextCure, Inc. (21.40M), less than Neoleukin Therapeutics, Inc. (-6333315.00), less than CytomX Therapeutics, Inc. (64.97M), less than Sensei Biotherapeutics, Inc. (5.58M), less than Merrimack Pharmaceuticals, Inc. (-10189682.00),

Build a custom stock screener for Graphite Bio, Inc. (GRPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Graphite Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Graphite Bio, Inc. (GRPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Graphite Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Graphite Bio, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Graphite Bio, Inc. (GRPH)?

What is the 3-year average Enterprise Value for Graphite Bio, Inc. (GRPH)?

What is the 5-year average Enterprise Value for Graphite Bio, Inc. (GRPH)?

How does the current Enterprise Value for Graphite Bio, Inc. (GRPH) compare to its historical average?